A Review of the Drug Treatment of Cachexia Associated with Cancer

@article{Gagnon2012ARO,
  title={A Review of the Drug Treatment of Cachexia Associated with Cancer},
  author={Bruno Gagnon and Eduardo Bruera},
  journal={Drugs},
  year={2012},
  volume={55},
  pages={675-688}
}
SummaryIn the past 20 years, cachexia in cancer patients has attracted increasing interest from both clinicians and basic researchers. It is now clear that the cachexia is secondary to major metabolic abnormalities due to tumour by-products and cytokine release. These metabolic abnormalities produce numerous symptoms such as cachexia, anorexia and asthenia.There are now effective drugs such as corticosteroids and progestational drugs that have been shown to improve appetite, food intake and… Expand
Cancer cachexia, mechanism and treatment.
TLDR
The emerging understanding of the mechanisms of cancer cachexia, the current treatment options including multidisciplinary combination therapies, as well an update on new and ongoing clinical trials are discussed. Expand
Managing Cancer-Related Anorexia/Cachexia
TLDR
Work on the potential role of antioxidant agents in counteracting the oxidative stress, which appears to be involved in CAC, shows them to be promising agents when used in combination chemotherapy regimens either alone or with other ‘biologics’. Expand
Cancer cachexia—pathophysiology and management
TLDR
The best treatment of the cachectic syndrome is a multifactorial approach, and health care providers must also recognize the psychosocial and biomedical impact cachexia can have. Expand
Cancer cachexia has many symptoms but only one cause: anoxia
TLDR
The aim of this paper is to show that the symptoms of cancer cachexia are many, but they have a single cause: anoxia, and surprisingly, there is one cause that explains all of its characteristics:anoxia. Expand
Appetite stimulants for patients with cancer: current evidence for clinical practice.
TLDR
Currently, there is no current standard of care for patients with cancer-related anorexia, and international guidelines recommend promoting anabolism through nutritional, physical, and pharmacologic therapies. Expand
The Science of Megestrol Acetate Delivery
TLDR
Preclinical pharmacokinetic data suggest that the new megestrol acetate formulation has the potential to significantly shorten the time to clinical response and thus may improve outcomes in patients with anorexia-cachexia. Expand
Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome.
  • S. Patra, S. Arora
  • Biology, Medicine
  • Clinica chimica acta; international journal of clinical chemistry
  • 2012
TLDR
There is a need to understand and explore the role of various neuropeptides and cytokines in the pathophysiology of cancer-anorexia syndrome so that therapeutic measures may be designed for effective palliative care. Expand
Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options
TLDR
There is a tendency toward an integrated multiple approach including nonpharmacological and pharmacological treatments, however, currently there is not enough evidence to support a change in clinical practice. Expand
Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer
TLDR
This study is the first randomized controlled trial to investigate the efficacy and the safety of using YGJT for treating patients with cancer-related anorexia in Korea and to establish whether or not it can be recommended as the primary therapy. Expand
Potential Novel Uses of Thalidomide
TLDR
Thalidomide therapy of diseases such as tuberculosis, sarcoidosis, aphthous ulcers in HIV syndrome and Behcet’s disease, rheumatoid arthritis, multiple myeloma, graft-versus-host disease, pyoderma gangrenosum, inflammatory bowel disease, Sjögren's syndrome and a variety of solid tumours is currently being explored. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 150 REFERENCES
Is there a role for melatonin in the treatment of neoplastic cachexia?
TLDR
It is suggested that the pineal hormone MLT may be effective in the treatment of the neoplastic cachexia by decreasing TNF blood concentrations. Expand
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
Medroxyprogesterone acetate (MEA) is widely used in oncology both in the treatment of hormonerelated cancers and as supportive therapy in anorexialcachexia syndrome (ACS), but conclusive data are notExpand
Megestrol Acetate in Patients with AIDS-related Cachexia
TLDR
This multicenter, double-blind, placebo-controlled study was designed to assess the safety and efficacy of megestrol acetate for the treatment of AIDS-related anorexia and cachexia in patients with AIDS-associated weight loss. Expand
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia
TLDR
A randomized, placebo‐controlled, double‐blinded clinical trial using cyproheptadine, 8 mg orally three times a day in 295 patients with advanced malignant disease found that it did not significantly abate progressive weight loss. Expand
Anorexia and cachexia in advanced cancer patients.
Cachexia is a frequent and devastating complication of advanced cancer. Current understanding of the pathophysiology of this syndrome implicates tumour induced metabolic changes and immune responses.Expand
Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.
TLDR
The results suggest that not only may prostaglandin synthesis inhibition offer palliative support to patients with solid advanced cancer, but it may also impact on pathways that ultimately determine outcome. Expand
Megestrol Acetate in Patients with AIDS and Cachexia
TLDR
This multicenter, double-blind, placebo-controlled clinical trial compared the effects of high-dose megestrol acetate and placebo on the medical status of patients with AIDS who had cachexia and anorexia. Expand
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
TLDR
This study failed to demonstrate any benefit of pentoxifylline at this dose and schedule as therapy for cancer anorexia and/or cachexia. Expand
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
TLDR
Data indicate that there was a significant increase in appetite in anorexic patients with advanced cancer treated with MPA which was reflected in increases in rapid turnover proteins reported to reflect nutritional status, but this apparent increased in appetite did not result in improved weight, performance status, energy levels, mood or relief of pain. Expand
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.
TLDR
A component fish oil, perhaps EPA, merits further investigation in the treatment of cancer cachexia, and changes in weight were accompanied by a temporary but significant reduction in acute phase protein production and by stabilisation of resting energy expenditure. Expand
...
1
2
3
4
5
...